课题基金 / 基金详情

Fluorescently Labeled Anti-EGFR to Guide Removal of Lymph Node Metastasis

Fluorescently Labeled Anti-EGFR to Guide Removal of Lymph Node Metastasis
荧光标记的抗 EGFR 指导清除淋巴结转移
批准号:
7738795
负责人:
EBEN L. ROSENTHAL
金额:
$18.3万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-01 至 2011-08-31

项目摘要

项目成果

EBEN L. ROSENTHAL的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):区域和远处转移的检测仍然主要依赖于非特异性解剖或代谢成像技术,这些技术不能为临床医生或外科医生提供实时信息,而临床医生或外科医生在诊断和治疗过程中依赖于主观标准来检测转移性疾病。荧光成像技术和靶向治疗的不断进步为外科医生和临床医生开发用于光学检测癌症的癌症特异性造影剂提供了独特的机会。我们假设荧光标记的抗EGFR抗体可用于检测和指导显微镜下区域和远处头颈癌转移的去除。为了验证这一假设,我们建议将荧光标记的单克隆抗EGFR抗体全身注射到携带HNSCC颈部转移或肺转移的免疫缺陷小鼠中,以确定该技术的潜在临床实用性。实验将针对确定的灵敏度和特异性的技术和估计的最小体积的肿瘤检测的这种方法。公共卫生相关性:我们建议,头颈部癌症的颈部淋巴结或肺转移的光学成像将显著提高疾病检测,有利于微创手术方法,并改善患者的预后。使用真实的时间光学成像后,注射全身肿瘤特异性造影剂,我们假设,亚临床疾病可以检测和删除。
英文摘要
DESCRIPTION (provided by applicant): Detection of regional and distant metastasis remains primarily dependent on non- specific anatomical or metabolic imaging techniques that cannot provide real-time information to clinicians or surgeons who depend upon subjective criteria for detection of metastatic disease during diagnostic and therapeutic procedures. Incremental advances in fluorescent imaging technology and targeted therapeutics have provided the unique opportunity for the development of cancer-specific contrast agents for optical detection of cancer by surgeons and clinicians. We hypothesize that fluorescently labeled anti- EGFR antibody can be used to detect and guide removal of microscopic regional and distant head and neck cancer metastasis. To test this hypothesis, we propose to systemically inject fluorescently labeled monoclonal anti-EGFR antibodies into immunodeficient mice bearing HNSCC cervical metastasis or pulmonary metastasis to determine the potential clinical utility of this technique. Experiments will be directed at determination of the sensitivity and specificity o the technique and estimation of the minimum volume of tumor detected by this method. PUBLIC HEALTH RELEVANCE: We propose that optical imaging of cervical lymph nodes or pulmonary metastasis of head and neck cancer will significantly improve disease detection, favor minimally invasive surgical approaches, and improve patient outcomes. Using real time optical imaging after injection of a systemic tumor-specific contrast agent, we hypothesize that subclinical disease could be detected and removed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
American Head and Neck International Conference
Targeted Dual Modality Imaging for Detection and Removal of Head and Neck Cancer
Targeted Dual Modality Imaging for Detection and Removal of Head and Neck Cancer
Next Generation Sentinel Node Mapping
海外基金